Abstract
Global Drug Delivery Devices Investment Opportunities, Analysis and Forecasts
to 2012
Summary
This report is an essential source for key information and data relating to
the Global drug delivery devices market. The report provides overview of key
trends, drivers and restraints, future outlook, pipeline products, news,
financial deals and competitive landscape and key developments in the Global
drug delivery devices market. It also offers global and country level,
detailed and comprehensive coverage of market revenue, volume, distribution
and company share information.
Scope
* This report provides detailed global, regional countries (United States,
Germany, United Kingdom, France, Italy, Spain, Japan, Canada, China, India,
Australia, Brazil) data on market size by volume and value for categories in
drug delivery devices market.
* It gives key company share information
for leading competitors, revenues by distribution channel and forecasts of
market values at global, regional and country level.
* It also provides
overview of the market structure, key trends, drivers and restraints, future
outlook, competitive landscape and key developments.
* All figures are
based on rigorous research methodologies including in-depth primary and
secondary research.
Reasons to buy
* A single source to fulfill all of your business and competitor intelligence
needs
* Gain a strong understanding of the drug delivery devices market at
a global level, with break downs for 12 countries
* Evaluate and compare
the attractiveness of the market in different geographies.
* Identify
growth segments and opportunities in the industry.
* Evaluate the pipeline
of key products that will change the sector, and identify threats and
opportunities before the products are launched.
* Analyze the
competitiveness of the market in different countries and regions and identify
hotspots.
* Develop strategies based on the latest product, brand,
expansion and research and development news.
* Do deals with an
understanding of how competitors are financed, and the mergers and
partnerships that have shaped the market.
* Identify and analyze the
strengths and weaknesses of the industry incumbents.
Table of Contents
1 Table Of Contents 2
1.1 List of Tables 10
1.2 List of Figures 16
2 Introduction 20
2.1 What Is This Report About? 20
3 Definitions of
Markets Covered in the Report 21
3.1 Drug delivery devices 21
3.2
Inhalation Systems 21
3.3 Infusion Systems 21
4 Market Dynamics -
Drivers, Restraints and Future Outlook 23
4.1 Needle-free injections
23
4.2 Inhalation Systems 23
4.3 Infusion Systems 24
5 Global Drug
Delivery Devices 25
5.1 Global Drug Delivery Devices, Overall Revenues ($
mn), 2000-2012 25
5.2 Global, Drug Delivery Devices, Category Volume
(Units), 2000-2012 29
5.3 Drug Delivery Devices, Global, Company Share
(2006-2007) 32
6 Drug Delivery Devices Cross Country Comparison 33
6.1
Drug Delivery Devices Devices Cross Country Comparison (2000-2012) 33
7
Drug Delivery Devices in United States 34
7.1 Drug Delivery Devices,
United States, Overall Revenues ($ mn), 2000-2012 34
7.2 Drug Delivery
Devices, United States, Category Volume (Units), 2000-2012 38
7.3 Drug
Delivery Devices, United States, Distribution Share (2006-2007) 41
7.4
Drug Delivery Devices, United States, Company Share (2006-2007) 43
8 Drug
Delivery Devices In Japan 46
8.1 Drug Delivery Devices, Japan, Overall
Revenues ($ mn), 2000-2012 46
8.2 Drug Delivery Devices, Japan, Category
Volume (Units), 2000-2012 50
8.3 Drug Delivery Devices, Japan,
Distribution Share (2006-2007) 53
8.4 Drug Delivery Devices, Japan,
Company Share (2006-2007) 55
9 Drug Delivery Devices in Germany 58
9.1
Drug Delivery Devices, Germany, Overall Revenues ($ mn), 2000-2012 58
9.2
Drug Delivery Devices, Germany, Category Volume (Units), 2000-2012 62
9.3
Drug Delivery Devices, Germany, Distribution Share (2006-2007) 65
9.4 Drug
Delivery Devices, Germany, Company Share (2006-2007) 67
10 Drug Delivery
Devices in France 70
10.1 Drug Delivery Devices, France, Overall Revenues
($ mn), 2000-2012 70
10.2 Drug Delivery Devices, France, Category Volume
(Units), 2000-2012 74
10.3 Drug Delivery Devices, France, Distribution
Share (2006-2007) 77
10.4 Drug Delivery Devices, France, Copmany Share
(2006-2007) 79
11 Drug Delivery Devices In China 82
11.1 Drug Delivery
Devices, China, Overall Revenues ($ mn), 2000-2012 82
11.2 Drug Delivery
Devices, China, Category Volume (Units), 2000-2012 86
11.3 Drug Delivery
Devices, China, Distribution Share (2006-2007) 89
11.4 Drug Delivery
Devices, China, Company Share (2006-2007) 90
12 Drug Delivery Devices in
United Kingdom 93
12.1 Drug Delivery Devices, United Kingdom, Overall
Revenues ($ mn), 2000-2012 93
12.2 Drug Delivery Devices, United Kingdom,
Category Volume (Units), 2000-2012 97
12.3 Drug Delivery Devices, United
Kingdom, Distribution Share (2006-2007) 100
12.4 Drug Delivery Devices,
United Kingdom, Company Share (2006-2007) 102
13 Drug Delivery Devices in
Italy 105
13.1 Drug Delivery Devices, Italy, Overall Revenues ($ mn),
2000-2012 105
13.2 Drug Delivery Devices, Italy, Category Volume (Units),
2000-2012 109
13.3 Drug Delivery Devices, Italy, Distribution Share
(2006-2007) 112
13.4 Drug Delivery Devices, Italy, Company Share
(2006-2007) 114
14 Drug Delivery Devices In Canada 117
14.1 Drug
Delivery Devices, Canada, Overall Revenues ($ mn), 2000-2012 117
14.2 Drug
Delivery Devices, Canada, Category Volume (Units), 2000-2012 121
14.3 Drug
Delivery Devices, Canada, Distribution Share (2006-2007) 124
14.4 Drug
Delivery Devices, Canada, Company Share (2006-2007) 126
15 Drug Delivery
Devices in Spain 129
15.1 Drug Delivery Devices, Spain, Overall Revenues
($ mn), 2000-2012 129
15.2 Drug Delivery Devices, Spain, Category Volume
(Units), 2000-2012 133
15.3 Drug Delivery Devices, Spain, Distribution
Share (2006-2007) 136
15.4 Drug Delivery Devices, Spain, Company Share
(2006-2007) 138
16 Drug Delivery Devices in Brazil 141
16.1 Drug
Delivery Devices, Brazil, Overall Revenues ($ mn), 2000-2012 141
16.2 Drug
Delivery Devices, Brazil, Category Volume (Units), 2000-2012 145
16.3 Drug
Delivery Devices, Brazil, Distribution Share (2006-2007) 148
16.4 Drug
Delivery Devices, Brazil, Company Share (2006-2007) 149
17 Drug Delivery
Devices In Australia 152
17.1 Drug Delivery Devices, Australia, Overall
Revenues ($ mn), 2000-2012 152
17.2 Drug Delivery Devices, Australia,
Category Volume (Units), 2000-2012 156
17.3 Drug Delivery Devices,
Australia, Distribution Share (2006-2007) 159
17.4 Drug Delivery Devices,
Australia, Company Share (2006-2007) 160
18 Drug Delivery Devices In India
163
18.1 Drug Delivery Devices, India, Overall Revenues ($ mn), 2000-2012
163
18.2 Drug Delivery Devices, India, Category Volume (Units), 2000-2012
167
18.3 Drug Delivery Devices, India, Distribution Share (2006-2007)
170
18.4 Drug Delivery Devices, India, Company Share (2006-2007) 171
19 AstraZeneca PLC Company Profile 175
19.1 Company Overview 175
20
GlaxoSmithKline plc Company Profile 176
20.1 Company Overview 176
21
Cardinal Health, Inc. Company Profile 177
21.1 Company Overview 177
21.2 Value Chain Analysis 177
22 3M Company Company Profile 180
22.1
Company Overview 180
22.2 Value Chain Analysis 180
23 Baxter
International Inc. Company Profile 183
23.1 Company Overview 183
23.2
Value Chain Analysis 183
24 Hospira, Inc. Company Profile 186
24.1
Company Overview 186
24.2 Value Chain Analysis 186
25 Boehringer
Ingelheim GmbH Company Profile 189
25.1 Company Overview 189
25.2
Value Chain Analysis 189
26 Novartis Medical Nutrition Company Profile
192
26.1 Company Overview 192
27 B. Braun Melsungen AG Company Profile
193
27.1 Company Overview 193
27.2 Value Chain Analysis 193
28
Fresenius Kabi AG Company Profile 197
28.1 Overview 197
28.2 Value
Chain Analysis 197
29 Glide Pharmaceutical Technologies Limited Company
Profile 200
29.1 Company Overview 200
29.2 Glide Pharmaceutical
Technologies Limited Pipeline Products 200
30 Antares Pharma, Inc. Company
Profile 201
30.1 Company Overview 201
30.2 Antares Pharma, Inc.
Pipeline Products 201
31 Bioject Medical Technologies Inc. Company Profile
203
31.1 Company Overview 203
31.2 Value Chain Analysis 203
31.3
Bioject Medical Technologies Inc. Pipeline Products 205
32 Corium
International, Inc. Company Profile 207
32.1 Company Overview 207
32.2
Corium International, Inc. Pipeline Products 207
33 Liquidia Technologies,
Inc. Company Profile 209
33.1 Company Overview 209
33.2 Liquidia
Technologies, Inc. Pipeline Products 209
34 pSivida Limited Company
Profile 210
34.1 Company Overview 210
34.2 pSivida Limited Pipeline
Products 210
35 Plenum Technologies Private Limited Company Profile
212
35.1 Company Overview 212
36 SEDAT Company Profile 213
36.1
Company Overview 213
37 SkyePharma PLC Company Profile 214
37.1
Company Overview 214
37.2 SkyePharma PLC Pipeline Products 214
38
TheraJect, Inc. Company Profile 215
38.1 Company Overview 215
38.2
TheraJect, Inc. Pipeline Products 215
39 Trudell Medical International
Company Profile 217
39.1 Company Overview 217
39.2 Trudell Medical
International Pipeline Products 217
40 Vectura Group plc Company Profile
218
40.1 Company Overview 218
40.2 Vectura Group plc Pipeline Products
218
41 Zogenix, Inc. Company Profile 219
41.1 Company Overview 219
41.2 Zogenix, Inc. Pipeline Products 219
42 Financial Deals Landscape
221
42.1 Venture Financing 221
42.2 Partnerships 225
42.3
Acquisition 228
43 Recent Developments 230
43.1 Product News 230
44 Appendix 232
44.1 Global Markets Direct Research Methodology 232
44.2 Coverage 233
44.3 Secondary Research 233
44.4 Primary Research
234
44.5 Models 234
44.6 Forecasts 235
44.7 Expert Panels 235
44.8 Currency Conversion 236
44.9 Contact Us 237
44.10 Disclaimer
237
List of Tables
1.1 List of Tables
Table 1: Global,
Drug Delivery Devices, Overall Revenues ($ mn), 2000-2012 30
Table 2:
Global, Drug Delivery Devices, Overall Revenues ($ mn), 2000-2012 31
Table
3: Global, Drug Delivery Devices, Overall Revenues ($ mn), Historic,
2000-2007 32
Table 4: Global, Drug Delivery Devices, Overall Revenues
($ mn), Forecast, 2007-2012 33
Table 5: Global, Drug Delivery
Devices, Category Volume (Units), 2000-2012 34
Table 6: Global, Drug
Delivery Devices, Category Volume (Units), Historic, 2000-2007 35
Table 7:
Global, Drug Delivery Devices, Category Volume (Units), Forecast,
2007-2012 36
Table 8: Drug Delivery Devices, Global, Company Share by
Revenue ($ mn), 2006-2007 37
Table 9: Drug Delivery Devices Cross
Country Comparison (2000-2012) 38
Table 10: Drug Delivery Devices,
United States, Overall Revenues ($ mn), 2000-2012 39
Table 11: Drug
Delivery Devices, United States, Overall Revenues ($ mn), 2000-2012 40
Table 12: Drug Delivery Devices, United States, Overall Revenues ($ mn),
Historic, 2000-2007 41
Table 13: Drug Delivery Devices, United
States, Overall Revenues ($ mn), Forecast, 2007-2012 42
Table 14:
Drug Delivery Devices, United States, Category Volume (Units), 2000-2012
43
Table 15: Drug Delivery Devices, United States, Category Volume
(Units), Historic, 2000-2007 44
Table 16: Drug Delivery Devices,
United States, Category Volume (Units), Forecast, 2007-2012 45
Table 17:
Infusion Systems, United States, Distribution Share by Revenue ($mn),
2006-2007 46
Table 18: Inhalation Systems, United States,
Distribution Share by Revenue ($mn), 2006-2007 46
Table 19: Needle
Free Injections, United States, Distribution Share by Revenue ($mn), 2006-2007
47
Table 20: Drug Delivery Devices, United States, Company Share by
Revenue ($ mn), 2006-2007 48
Table 21: Infusion Systems, United
States, Company Share by Revenue ($ mn), 2006-2007 49
Table 22:
Inhalation Systems, United States, Company Share by Revenue ($ mn), 2006-2007
50
Table 23: Drug Delivery Devices, Japan, Overall Revenues ($ mn),
2000-2012 51
Table 24: Drug Delivery Devices, Japan, Overall Revenues
($ mn), 2000-2012 52
Table 25: Drug Delivery Devices, Japan, Overall
Revenues ($ mn), Historic, 2000-2007 53
Table 26: Drug Delivery
Devices, Japan, Overall Revenues ($ mn), Forecast, 2007-2012 54
Table 27:
Drug Delivery Devices, Japan, Category Volume (Units), 2000-2012 55
Table 28: Drug Delivery Devices, Japan, Category Volume (Units),
Historic, 2000-2007 56
Table 29: Drug Delivery Devices, Japan,
Category Volume (Units), Forecast, 2007-2012 57
Table 30: Infusion
Systems, Japan, Distribution Share by Revenue ($mn), 2006-2007 58
Table
31: Inhalation Systems, Japan, Distribution Share by Revenue ($mn),
2006-2007 58
Table 32: Needle Free Injections, Japan, Distribution
Share by Revenue ($mn), 2006-2007 59
Table 33: Drug Delivery Devices,
Japan, Company Share by Revenue ($ mn), 2006-2007 60
Table 34:
Infusion Systems, Japan, Company Share by Revenue ($ mn), 2006-2007 61
Table 35: Inhalation Systems, Japan, Company Share by Revenue ($ mn),
2006-2007 62
Table 36: Drug Delivery Devices, Germany, Overall
Revenues ($ mn), 2000-2012 63
Table 37: Drug Delivery Devices,
Germany, Portfolio Analysis, 2000-2012 64
Table 38: Drug Delivery
Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007 65
Table
39: Drug Delivery Devices, Germany, Overall Revenues ($ mn), Forecast,
2007-2012 66
Table 40: Drug Delivery Devices, Germany, Category
Volume (Units), 2000-2012 67
Table 41: Drug Delivery Devices,
Germany, Category Volume (Units), Historic, 2000-2007 68
Table 42:
Drug Delivery Devices, Germany, Category Volume (Units), Forecast, 2007-2012
69
Table 43: Infusion Systems, Germany, Distribution Share by Revenue
($mn), 2006-2007 70
Table 44: Inhalation Systems, Germany,
Distribution Share by Revenue ($mn), 2006-2007 70
Table 45: Needle
Free Injections, Germany, Distribution Share by Revenue ($mn), 2006-2007
71
Table 46: Drug Delivery Devices, Germany Company share by Revenue
($ mn), 2006-2007 72
Table 47: Infusion Systems, Germany, Company
Share by Revenue ($ mn), 2006-2007 73
Table 48: Inhalation Systems,
Germany, Company Share by Revenue ($ mn), 2006-2007 74
Table 49: Drug
Delivery Devices, France, Overall Revenues ($ mn), 2000-2012 75
Table 50:
Drug Delivery Devices, France, Portfolio Analysis, 2000-2012 76
Table
51: Drug Delivery Devices, France, Overall Revenues ($ mn), Historic,
2000-2007 77
Table 52: Drug Delivery Devices, France, Overall
Revenues ($ mn), Forecast, 2007-2012 78
Table 53: Drug Delivery
Devices, France, Category Volume (Units), 2000-2012 79
Table 54: Drug
Delivery Devices, France, Category Volume (Units), Historic, 2000-2007 80
Table 55: Drug Delivery Devices, France, Category Volume (Units),
Forecast, 2007-2012 81
Table 56: Infusion Systems, France,
Distribution Share by Revenue ($mn), 2006-2007 82
Table 57:
Inhalation Systems, France, Distribution Share by Revenue ($mn), 2006-2007
82
Table 58: Needle Free Injections, France, Distribution Share by
Revenue ($mn), 2006-2007 83
Table 59: Drug Delivery Devices, France,
Company Share by Revenue ($ mn), 2006-2007 84
Table 60: Infusion
Systems, France, Company Share by Revenue ($ mn), 2006-2007 85
Table 61:
Inhalation Systems, France, Company Share by Revenue ($ mn), 2006-2007
86
Table 62: Drug Delivery Devices, China, Overall Revenues ($ mn),
2000-2012 87
Table 63: Drug Delivery Devices, China, Overall Revenues
($ mn), 2000-2012 88
Table 64: Drug Delivery Devices, China, Overall
Revenues ($ mn), Historic, 2000-2007 89
Table 65: Drug Delivery
Devices, China, Overall Revenues ($ mn), Forecast, 2007-2012 90
Table 66:
Drug Delivery Devices, China, Category Volume (Units), 2000-2012 91
Table 67: Drug Delivery Devices, China, Category Volume (Units),
Historic, 2000-2007 92
Table 68: Drug Delivery Devices, China,
Category Volume (Units), Forecast, 2007-2012 93
Table 69: Infusion
Systems, China, Distribution Share by Revenue ($mn), 2006-2007 94
Table
70: Inhalation Systems, China, Distribution Share by Revenue ($mn),
2006-2007 94
Table 71: Drug Delivery Devices, China, Company Share by
Revenue ($ mn), 2006-2007 95
Table 72: Infusion Systems, China,
Company Share by Revenue ($ mn), 2006-2007 96
Table 73: Inhalation
Systems, China, Company Share by Revenue ($ mn), 2006-2007 97
Table 74:
Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
98
Table 75: Drug Delivery Devices, United Kingdom, Portfolio
Analysis, 2000-2012 99
Table 76: Drug Delivery Devices, United
Kingdom, Overall Revenues ($ mn), Historic, 2000-2007 100
Table 77:
Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), Forecast,
2007-2012 101
Table 78: Drug Delivery Devices, United Kingdom,
Category Volume (Units), 2000-2012 102
Table 79: Drug Delivery
Devices, United Kingdom, Category Volume (Units), Historic, 2000-2007 103
Table 80: Drug Delivery Devices, United Kingdom, Category Volume (Units),
Forecast, 2007-2012 104
Table 81: Infusion Systems, United Kingdom,
Distribution Share by Revenue ($mn), 2006-2007 105
Table 82:
Inhalation Systems, United Kingdom, Distribution Share by Revenue ($mn),
2006-2007 105
Table 83: Needle Free Injections, United Kingdom,
Distribution Share by Revenue ($mn), 2006-2007 106
Table 84: Drug
Delivery Devices, United Kingdom Company share by Revenue ($ mn), 2006-2007
107
Table 85: Infusion Systems, United Kingdom, Company Share by
Revenue ($ mn), 2006-2007 108
Table 86: Inhalation Systems, United
Kingdom, Company Share by Revenue ($ mn), 2006-2007 109
Table 87:
Drug Delivery Devices, Italy, Overall Revenues ($ mn), 2000-2012 110
Table
88: Drug Delivery Devices, Italy, Portfolio Analysis, 2000-2012 111
Table 89: Drug Delivery Devices, Italy, Overall Revenues ($ mn),
Historic, 2000-2007 112
Table 90: Drug Delivery Devices, Italy,
Overall Revenues ($ mn), Forecast, 2007-2012 113
Table 91: Drug
Delivery Devices, Italy, Category Volume (Units), 2000-2012 114
Table 92:
Drug Delivery Devices, Italy, Category Volume (Units), Historic, 2000-2007
115
Table 93: Drug Delivery Devices, Italy, Category Volume (Units),
Forecast, 2007-2012 116
Table 94: Infusion Systems, Italy,
Distribution Share by Revenue ($mn), 2006-2007 117
Table 95:
Inhalation Systems, Italy, Distribution Share by Revenue ($mn), 2006-2007
117
Table 96: Needle Free Injections, Italy, Distribution Share by
Revenue ($mn), 2006-2007 118
Table 97: Drug Delivery Devices, Italy,
Company Share by Revenue ($ mn), 2006-2007 119
Table 98: Infusion
Systems, Italy, Company Share by Revenue ($ mn), 2006-2007 120
Table 99:
Inhalation Systems, Italy, Company Share by Revenue ($ mn), 2006-2007
121
Table 100: Drug Delivery Devices, Canada, Overall Revenues ($
mn), 2000-2012 122
Table 101: Drug Delivery Devices, Canada, Overall
Revenues ($ mn), 2000-2012 123
Table 102: Drug Delivery Devices,
Canada, Overall Revenues ($ mn), Historic, 2000-2007 124
Table 103:
Drug Delivery Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
125
Table 104: Drug Delivery Devices, Canada, Category Volume
(Units), 2000-2012 126
Table 105: Drug Delivery Devices, Canada,
Category Volume (Units), Historic, 2000-2007 127
Table 106: Drug
Delivery Devices, Canada, Category Volume (Units), Forecast, 2007-2012 128
Table 107: Infusion Systems, Canada, Distribution Share by Revenue ($mn),
2006-2007 129
Table 108: Inhalation Systems, Canada, Distribution
Share by Revenue ($mn), 2006-2007 129
Table 109: Needle Free
Injections, Canada, Distribution Share by Revenue ($mn), 2006-2007 130
Table 110: Drug Delivery Devices, Canada, Company Share by Revenue ($
mn), 2006-2007 131
Table 111: Infusion Systems, Canada, Company Share
by Revenue ($ mn), 2006-2007 132
Table 112: Inhalation Systems,
Canada, Company Share by Revenue ($ mn), 2006-2007 133
Table 113:
Drug Delivery Devices, Spain, Overall Revenues ($ mn), 2000-2012 134
Table
114: Drug Delivery Devices, Spain, Portfolio Analysis, 2000-2012 135
Table 115: Drug Delivery Devices, Spain, Overall Revenues ($ mn),
Historic, 2000-2007 136
Table 116: Drug Delivery Devices, Spain,
Overall Revenues ($ mn), Forecast, 2007-2012 137
Table 117: Drug
Delivery Devices, Spain, Category Volume (Units), 2000-2012 138
Table 118:
Drug Delivery Devices, Spain, Category Volume (Units), Historic,
2000-2007 139
Table 119: Drug Delivery Devices, Spain, Category
Volume (Units), Forecast, 2007-2012 140
Table 120: Infusion Systems,
Spain, Distribution Share by Revenue ($mn), 2006-2007 141
Table 121:
Inhalation Systems, Spain, Distribution Share by Revenue ($mn), 2006-2007
141
Table 122: Needle Free Injections, Spain, Distribution Share by
Revenue ($mn), 2006-2007 142
Table 123: Drug Delivery Devices, Spain
Company share by Revenue ($ mn), 2006-2007 143
Table 124: Infusion
Systems, Spain, Company Share by Revenue ($ mn), 2006-2007 144
Table 125:
Inhalation Systems, Spain, Company Share by Revenue ($ mn), 2006-2007
145
Table 126: Drug Delivery Devices, Brazil, Overall Revenues ($
mn), 2000-2012 146
Table 127: Drug Delivery Devices, Brazil,
Portfolio Analysis, 2000-2012 147
Table 128: Drug Delivery Devices,
Brazil, Overall Revenues ($ mn), Historic, 2000-2007 148
Table 129:
Drug Delivery Devices, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012
149
Table 130: Drug Delivery Devices, Brazil, Category Volume
(Units), 2000-2012 150
Table 131: Drug Delivery Devices, Brazil,
Category Volume (Units), Historic, 2000-2007 151
Table 132: Drug
Delivery Devices, Brazil, Category Volume (Units), Forecast, 2007-2012 152
Table 133: Infusion Systems, Brazil, Distribution Share by Revenue ($mn),
2006-2007 153
Table 134: Inhalation Systems, Brazil, Distribution
Share by Revenue ($mn), 2006-2007 153
Table 135: Drug Delivery
Devices, Brazil Company share by Revenue ($ mn), 2006-2007 154
Table 136:
Infusion Systems, Brazil, Company Share by Revenue ($ mn), 2006-2007
155
Table 137: Inhalation Systems, Brazil, Company Share by Revenue
($ mn), 2006-2007 156
Table 138: Drug Delivery Devices, Australia,
Overall Revenues ($ mn), 2000-2012 157
Table 139: Drug Delivery
Devices, China, Overall Revenues ($ mn), 2000-2012 158
Table 140:
Drug Delivery Devices, Australia, Overall Revenues ($ mn), Historic, 2000-2007
159
Table 141: Drug Delivery Devices, Australia, Overall Revenues ($
mn), Forecast, 2007-2012 160
Table 142: Drug Delivery Devices,
Australia, Category Volume (Units), 2000-2012 161
Table 143: Drug
Delivery Devices, Australia, Category Volume (Units), Historic, 2000-2007
162
Table 144: Drug Delivery Devices, Australia, Category Volume
(Units), Forecast, 2007-2012 163
Table 145: Infusion Systems,
Australia, Distribution Share by Revenue ($mn), 2006-2007 164
Table 146:
Inhalation Systems, Australia, Distribution Share by Revenue ($mn),
2006-2007 164
Table 147: Drug Delivery Devices, Australia, Company
Share by Revenue ($ mn), 2006-2007 165
Table 148: Infusion Systems,
Australia, Company Share by Revenue ($ mn), 2006-2007 166
Table 149:
Inhalation Systems, Australia, Company Share by Revenue ($ mn), 2006-2007
167
Table 150: Drug Delivery Devices, India, Overall Revenues ($ mn),
2000-2012 168
Table 151: Drug Delivery Devices, China, Overall
Revenues ($ mn), 2000-2012 169
Table 152: Drug Delivery Devices,
India, Overall Revenues ($ mn), Historic, 2000-2007 170
Table 153:
Drug Delivery Devices, India, Overall Revenues ($ mn), Forecast, 2007-2012
171
Table 154: Drug Delivery Devices, India, Category Volume (Units),
2000-2012 172
Table 155: Drug Delivery Devices, India, Category
Volume (Units), Historic, 2000-2007 173
Table 156: Drug Delivery
Devices, India, Category Volume (Units), Forecast, 2007-2012 174
Table
157: Infusion Systems, India, Distribution Share by Revenue ($mn),
2006-2007 175
Table 158: Inhalation Systems, India, Distribution
Share by Revenue ($mn), 2006-2007 175
Table 159: Drug Delivery
Devices, India, Company Share by Revenue ($ mn), 2006-2007 176
Table 160:
Infusion Systems, India, Company Share by Revenue ($ mn), 2006-2007
178
Table 161: Inhalation Systems, India, Company Share by Revenue ($
mn), 2006-2007 179
Table 162: Glide Pharmaceutical Technologies
Limited Pipeline Products by Equipment Type 205
Table 163: Glide
Pharmaceutical Technologies Limited Pipeline Products by Development Stage
205
Table 164: Glide Pharmaceutical Technologies Limited Pipeline
Products by Therapy Area 205
Table 165: Antares Pharma, Inc. Pipeline
Products by Equipment Type 206
Table 166: Antares Pharma, Inc.
Pipeline Products by Development Stage 206
Table 167: Antares Pharma,
Inc. Pipeline Products by Therapy Area 206
Table 168: Antares Pharma,
Inc. Pipeline Products by Clinical Trials 207
Table 169: Antares
Pharma, Inc. Pipeline Products by News Summaries 207
Table 170:
Bioject Medical Technologies Inc. Pipeline Products by Equipment Type 210
Table 171: Bioject Medical Technologies Inc. Pipeline Products by
Development Stage 210
Table 172: Bioject Medical Technologies Inc.
Pipeline Products by Therapy Area 211
Table 173: Bioject Medical
Technologies Inc. Pipeline Products by News Summaries 211
Table 174:
Corium International, Inc. Pipeline Products by Equipment Type 212
Table
175: Corium International, Inc. Pipeline Products by Development Stage
212
Table 176: Corium International, Inc. Pipeline Products by
Therapy Area 212
Table 177: Corium International, Inc. Pipeline
Products by News Summaries 213
Table 178: Liquidia Technologies, Inc.
Pipeline Products by Equipment Type 214
Table 179: Liquidia
Technologies, Inc. Pipeline Products by Development Stage 214
Table 180:
Liquidia Technologies, Inc. Pipeline Products by Therapy Area 214
Table
181: pSivida Limited Pipeline Products by Equipment Type 215
Table
182: pSivida Limited Pipeline Products by Development Stage 215
Table
183: pSivida Limited Pipeline Products by Therapy Area 215
Table 184:
pSivida Limited Pipeline Products by Clinical Trials 216
Table 185:
pSivida Limited Pipeline Products by News Summaries 216
Table 186:
SkyePharma PLC Pipeline Products by Equipment Type 219
Table 187:
SkyePharma PLC Pipeline Products by Development Stage 219
Table 188:
SkyePharma PLC Pipeline Products by Therapy Area 219
Table 189:
TheraJect, Inc. Pipeline Products by Equipment Type 220
Table 190:
TheraJect, Inc. Pipeline Products by Development Stage 220
Table 191:
TheraJect, Inc. Pipeline Products by Therapy Area 220
Table 192:
TheraJect, Inc. Pipeline Products by Clinical Trials 221
Table 193:
Trudell Medical International Pipeline Products by Equipment Type 222
Table 194: Trudell Medical International Pipeline Products by Development
Stage 222
Table 195: Trudell Medical International Pipeline Products
by Therapy Area 222
Table 196: Vectura Group plc Pipeline Products by
Equipment Type 223
Table 197: Vectura Group plc Pipeline Products by
Development Stage 223
Table 198: Vectura Group plc Pipeline Products
by Therapy Area 223
Table 199: Zogenix, Inc. Pipeline Products by
Equipment Type 224
Table 200: Zogenix, Inc. Pipeline Products by
Development Stage 224
Table 201: Zogenix, Inc. Pipeline Products by
Therapy Area 224
Table 202: Zogenix, Inc. Pipeline Products by
Clinical Trials 225
Table 203: Zogenix, Inc. Pipeline Products by
News Summaries 225
Table 204: POINT Biomedical Secures $25 Million In
Venture Financing 226
Table 205: Medipacs Secures $1.65 Million In
Financing Round 228
Table 206: Glide Pharma Secures $3.75 Million In
Financing 229
Table 207: Stallergenes Enters Into An Agreement With
Catalent Pharma Solutions And The Medical House 230
Table 208: Merck
& Co Terminates License Agreement With SurModics 231
Table 209: Lupin
Enters Into An Agreement With Forest Laboratories 232
Table 210:
Presspart Acquires Nemo 233
Table 211: Mundipharma International
Acquires Clinical Designs From Abingworth Management 234
Table 212:
Currency Conversion from USD to Local Currency at 2007 Constant Rate 241
List of Figures
1.2 List of Figures
Figure 1: Global Drug
Delivery Devices, Overall Revenues ($ mn), 2000-2012 30
Figure 2: Global,
Drug Delivery Devices, Portfolio Analysis, 2000-2012 31
Figure 3:
Global, Drug Delivery Devices, Overall Revenues ($ mn), Historic, 2000-2007
32
Figure 4: Global, Drug Delivery Devices, Overall Revenues ($ mn),
Forecast, 2007-2012 33
Figure 5: Global, Drug Delivery Devices,
Category Volume (Units), 2000-2012 34
Figure 6: Global, Drug Delivery
Devices, Category Volume (Units), Historic, 2000-2007 35
Figure 7:
Global, Drug Delivery Devices, Category Volume (Units), Forecast, 2007-2012
36
Figure 8: Drug Delivery Devices, Global, Company Share (%), 2007
37
Figure 9: Drug Delivery Devices Cross Country Comparison
(2000-2012) 38
Figure 10: Drug Delivery Devices, United States,
Overall Revenues ($ mn), 2000-2012 39
Figure 11: Drug Delivery Devices,
United States, Portfolio Analysis, 2000-2012 40
Figure 12: Drug
Delivery Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007
41
Figure 13: Drug Delivery Devices, United States, Overall Revenues
($ mn), Forecast, 2007-2012 42
Figure 14: Drug Delivery Devices,
United States, Category Volume (Units), 2000-2012 43
Figure 15: Drug
Delivery Devices, United States, Category Volume (Units), Historic, 2000-2007
44
Figure 16: Drug Delivery Devices, United States, Category Volume
(Units), Forecast, 2007-2012 45
Figure 17: Drug Delivery Devices,
United States, Company Share (%), 2007 48
Figure 18: Infusion
Systems, United States, Company Share (%), 2007 49
Figure 19:
Inhalation Systems, United States, Company Share (%), 2007 50
Figure 20:
Drug Delivery Devices, Japan, Overall Revenues ($ mn), 2000-2012 51
Figure 21: Drug Delivery Devices, Japan, Portfolio Analysis, 2000-2012 52
Figure 22: Drug Delivery Devices, Japan, Overall Revenues ($ mn),
Historic, 2000-2007 53
Figure 23: Drug Delivery Devices, Japan,
Overall Revenues ($ mn), Forecast, 2007-2012 54
Figure 24: Drug
Delivery Devices, Japan, Category Volume (Units), 2000-2012 55
Figure 25:
Drug Delivery Devices, Japan, Category Volume (Units), Historic, 2000-2007
56
Figure 26: Drug Delivery Devices, Japan, Category Volume (Units),
Forecast, 2007-2012 57
Figure 27: Drug Delivery Devices, Japan,
Company Share (%), 2007 60
Figure 28: Infusion Systems, Japan,
Company Share (%), 2007 61
Figure 29: Inhalation Systems, Japan,
Company Share (%), 2007 62
Figure 30: Drug Delivery Devices, Germany,
Overall Revenues ($ mn), 2000-2012 63
Figure 31: Drug Delivery Devices,
Germany, Portfolio Analysis, 2000-2012 64
Figure 32: Drug Delivery
Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007 65
Figure
33: Drug Delivery Devices, Germany, Overall Revenues ($ mn), Forecast,
2007-2012 66
Figure 34: Drug Delivery Devices, Germany, Category
Volume (Units), 2000-2012 67
Figure 35: Drug Delivery Devices,
Germany, Category Volume (Units), Historic, 2000-2007 68
Figure 36:
Drug Delivery Devices, Germany, Category Volume (Units), Forecast, 2007-2012
69
Figure 37: Drug Delivery Devices, Germany, Company Share (%), 2007
72
Figure 38: Infusion Systems, Germany, Company Share (%), 2007
73
Figure 39: Inhalation Systems, Germany, Company Share (%), 2007
74
Figure 40: Drug Delivery Devices, France, Overall Revenues ($ mn),
2000-2012 75
Figure 41: Drug Delivery Devices, France, Portfolio Analysis,
2000-2012 76
Figure 42: Drug Delivery Devices, France, Overall
Revenues ($ mn), Historic, 2000-2007 77
Figure 43: Drug Delivery
Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012 78
Figure
44: Drug Delivery Devices, France, Category Volume (Units), 2000-2012
79
Figure 45: Drug Delivery Devices, France, Category Volume (Units),
Historic, 2000-2007 80
Figure 46: Drug Delivery Devices, France,
Category Volume (Units), Forecast, 2007-2012 81
Figure 47: Drug
Delivery Devices, France, Company Share (%), 2007 84
Figure 48:
Infusion Systems, France, Company Share (%), 2007 85
Figure 49:
Inhalation Systems, France, Company Share (%), 2007 86
Figure 50:
Drug Delivery Devices, China, Overall Revenues ($ mn), 2000-2012 87
Figure
51: Drug Delivery Devices, China, Portfolio Analysis, 2000-2012 88
Figure
52: Drug Delivery Devices, China, Overall Revenues ($ mn), Historic,
2000-2007 89
Figure 53: Drug Delivery Devices, China, Overall
Revenues ($ mn), Forecast, 2007-2012 90
Figure 54: Drug Delivery
Devices, China, Category Volume (Units), 2000-2012 91
Figure 55: Drug
Delivery Devices, China, Category Volume (Units), Historic, 2000-2007 92
Figure 56: Drug Delivery Devices, China, Category Volume (Units),
Forecast, 2007-2012 93
Figure 57: Drug Delivery Devices, China,
Company Share (%), 2007 95
Figure 58: Infusion Systems, China,
Company Share (%), 2007 96
Figure 59: Inhalation Systems, China,
Company Share (%), 2007 97
Figure 60: Drug Delivery Devices, United
Kingdom, Overall Revenues ($ mn), 2000-2012 98
Figure 61: Drug Delivery
Devices, United Kingdom, Portfolio Analysis, 2000-2012 99
Figure 62:
Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), Historic,
2000-2007 100
Figure 63: Drug Delivery Devices, United Kingdom,
Overall Revenues ($ mn), Forecast, 2007-2012 101
Figure 64: Drug
Delivery Devices, United Kingdom, Category Volume (Units), 2000-2012 102
Figure 65: Drug Delivery Devices, United Kingdom, Category Volume
(Units), Historic, 2000-2007 103
Figure 66: Drug Delivery Devices,
United Kingdom, Category Volume (Units), Forecast, 2007-2012 104
Figure
67: Drug Delivery Devices, United Kingdom, Company Share (%), 2007
107
Figure 68: Infusion Systems, United Kingdom, Company Share (%),
2007 108
Figure 69: Inhalation Systems, United Kingdom, Company Share
(%), 2007 109
Figure 70: Drug Delivery Devices, Italy, Overall
Revenues ($ mn), 2000-2012 110
Figure 71: Drug Delivery Devices, Italy,
Portfolio Analysis, 2000-2012 111
Figure 72: Drug Delivery Devices,
Italy, Overall Revenues ($ mn), Historic, 2000-2007 112
Figure 73:
Drug Delivery Devices, Italy, Overall Revenues ($ mn), Forecast, 2007-2012
113
|
相關報告
|
